Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Accelerate Diagnosti (AXDX)
Accelerate Diagnosti (AXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 70,881
  • Shares Outstanding, K 99,832
  • Annual Sales, $ 12,750 K
  • Annual Income, $ -62,490 K
  • 60-Month Beta 1.19
  • Price/Sales 5.87
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AXDX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.73
  • Most Recent Earnings -0.17 on 05/11/23
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 268.65% ( -2.79%)
  • Historical Volatility 67.51%
  • IV Percentile 53%
  • IV Rank 21.39%
  • IV High 1,088.53% on 01/19/23
  • IV Low 45.51% on 07/21/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 11
  • Put/Call OI Ratio 0.47
  • Today's Open Interest 1,254
  • Open Int (30-Day) 1,330

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -0.15
  • Number of Estimates 1
  • High Estimate -0.15
  • Low Estimate -0.15
  • Prior Year -0.24
  • Growth Rate Est. (year over year) +37.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6626 +8.03%
on 05/30/23
0.8430 -15.09%
on 05/16/23
-0.0942 (-11.63%)
since 05/05/23
3-Month
0.4501 +59.03%
on 03/09/23
0.9199 -22.19%
on 04/25/23
+0.2198 (+44.31%)
since 03/06/23
52-Week
0.4501 +59.03%
on 03/09/23
3.7370 -80.85%
on 08/17/22
+0.0052 (+0.73%)
since 06/06/22

Most Recent Stories

More News
Accelerate Diagnostics: Q1 Earnings Snapshot

Accelerate Diagnostics: Q1 Earnings Snapshot

AXDX : 0.7158 (+0.82%)
Accelerate Diagnostics Reports First Quarter 2023 Financial Results

/PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the first quarter for the period ended March 31, 2023. "Our...

AXDX : 0.7158 (+0.82%)
Syneos Health (SYNH) Announces a $7.1 Billion Merger Agreement

Syneos Health (SYNH) is set to become private company following a $7.1 billion merger deal to be acquired by a private investment consortium.

SYNH : 41.53 (-0.12%)
AXDX : 0.7158 (+0.82%)
PEN : 322.37 (+0.17%)
SIBN : 27.67 (+3.02%)
Walgreens Boots (WBA) New Alliances Aid Growth, Cost Woe Stays

Intensifying competition in the U.S. pharmacy retail drugstore market compels Walgreens Boots (WBA) to diversify its product offerings through new partnerships.

WBA : 31.53 (+0.90%)
AXDX : 0.7158 (+0.82%)
PEN : 322.37 (+0.17%)
SIBN : 27.67 (+3.02%)
Penumbra (PEN) Hits 52-Week High: What's Driving the Rise?

Penumbra (PEN) outperforms the industry and the S&P 500, backed by investors' optimism about the recently released first-quarter 2023 results.

PEN : 322.37 (+0.17%)
OMI : 20.77 (-1.56%)
AXDX : 0.7158 (+0.82%)
SIBN : 27.67 (+3.02%)
Thermo Fisher (TMO) Partners With Pfizer to Expand NGS Testing

Thermo Fisher's (TMO) latest collaboration with Pfizer is set to enhance localized access to NGS-based testing capabilities for breast and lung cancer across international markets.

TMO : 516.26 (-0.45%)
AXDX : 0.7158 (+0.82%)
PEN : 322.37 (+0.17%)
SIBN : 27.67 (+3.02%)
Stereotaxis Inc. (STXS) Reports Q1 Loss, Tops Revenue Estimates

Stereotaxis Inc. (STXS) delivered earnings and revenue surprises of -40% and 0.74%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

STXS : 2.17 (+1.88%)
AXDX : 0.7158 (+0.82%)
Accelerate Diagnostics scheduled call to review 2023 first quarter results

/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, May 11, 2023, at 4:30 p.m....

AXDX : 0.7158 (+0.82%)
Zacks.com featured highlights include Disney, Casey's General Stores, OpGen, Accelerate Diagnostics and Nektar Therapeutics

Disney, Casey's General Stores, OpGen, Accelerate Diagnostics and Nektar Therapeutics are part of the Zacks Screen of the Week article.

DIS : 92.16 (+1.27%)
NKTR : 0.6092 (-0.13%)
CASY : 224.26 (-1.61%)
AXDX : 0.7158 (+0.82%)
OPGN : 0.6400 (-7.23%)
Forget Bargain Hunting, Buy 5 Stocks With Rising P/E

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Disney (DIS), Casey's General Stores (CASY), OpGen (OPGN), Accelerate Diagnostics (AXDX) and Nektar...

DIS : 92.16 (+1.27%)
NKTR : 0.6092 (-0.13%)
CASY : 224.26 (-1.61%)
AXDX : 0.7158 (+0.82%)
OPGN : 0.6400 (-7.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections...

See More

Key Turning Points

3rd Resistance Point 0.7955
2nd Resistance Point 0.7653
1st Resistance Point 0.7405
Last Price 0.7158
1st Support Level 0.6855
2nd Support Level 0.6553
3rd Support Level 0.6305

See More

52-Week High 3.7370
Fibonacci 61.8% 2.4814
Fibonacci 50% 2.0935
Fibonacci 38.2% 1.7057
Last Price 0.7158
52-Week Low 0.4501

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar